A molecular perspective for the use of type IV tyrosine kinase inhibitors as anticancer therapeutics

Area of Science:

• Biochemistry
• Enzymology
• Pharmacology

Background:

• Tyrosine kinases regulate cellular processes by transferring phosphate groups from ATP.
• Mutations in tyrosine kinases can lead to an overactive state, contributing to various diseases.
• While inhibitors for types I-III and V-VII are well-documented, type IV inhibitors remain under-explored.

Purpose of the Study:

• To consolidate current knowledge on type IV kinase inhibitors.
• To highlight recent progress in the development of type IV inhibitors.
• To address the existing gap in the literature regarding type IV kinase inhibition.

Main Methods:

• Literature review of scientific databases.
• Analysis of recent research on tyrosine kinase inhibitors.
• Synthesis of information on type IV kinase inhibitor development.

Main Results:

• Identification of emerging research trends in type IV kinase inhibition.
• Compilation of known type IV kinase inhibitors and their mechanisms.
• Overview of the challenges and opportunities in targeting type IV kinases.

Conclusions:

• Type IV kinase inhibitors represent a promising but understudied area in drug discovery.
• Further research is crucial to fully understand and exploit type IV kinase inhibitors for therapeutic purposes.
• Recent advances suggest a growing interest and potential for future development in this field.